AtriCure (ATRC) Enterprise Value (2010 - 2026)

AtriCure (ATRC) has reported Enterprise Value for 17 consecutive years, with $1.3 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Enterprise Value fell 16.9% year-over-year to $1.3 billion in Q2 2026; TTM through Jun 2026 was $1.3 billion, a 16.9% decrease from a year earlier, with the FY2025 full-year figure at $1.8 billion, up 31.49% from the prior year.
• Enterprise Value was $1.3 billion for Q2 2026 at AtriCure, down from $1.3 billion in the prior quarter.
• Over five years, Enterprise Value peaked at $2.9 billion in Q1 2022 and troughed at $994.6 million in Q2 2024.
• A 5-year average of $1.7 billion and a median of $1.6 billion in 2023 frame the typical range for Enterprise Value.
• Across the five-year window, Enterprise Value slumped 55.0% in 2024 and jumped 51.88% in 2025, its largest moves.
• Over 5 years, Enterprise Value stood at $1.9 billion in 2022, then retreated by 19.86% to $1.6 billion in 2023, then declined by 12.07% to $1.4 billion in 2024, then jumped by 31.49% to $1.8 billion in 2025, then plunged by 30.35% to $1.3 billion in 2026.
• The last three Enterprise Value figures came in at $1.3 billion (Q2 2026), $1.3 billion (Q1 2026), and $1.8 billion (Q4 2025), per Business Quant data.